Investor Presentaiton

IV Appendix Balance Sheet In EGP Property & Equipment, net Leased Assets, net Intangible Assets Projects Under Construction, net Long Term NR Deferred Tax Total Long-term Assets Inventories Trade & Notes receivable, net Supplier Advances Debtors & Other Debit Balance, net Due from Related Parties FY2018 438,419,837 FY2019 898,219,923 7,641,002 61,477,457 8,493,759 336,288,113 10,998,195 160,909,990 101,034,892 10,453,533 803,800,680 9,255,549 1,239,391,570 1,400,352,259 1,690,645,175 3,637,234,781 4,457,391,080 213,861,597 203,885,499 371,635 233,423,351 430,197,609 371,635 118,462,800 Cash & Cash Equivalent Total Current Assets Total Assets Paid-In Capital Share Premium General Reserve Legal Reserve Retained Earnings 96,618,121 5,552,323,892 6,930,491,650 6,356,124,572 8,169,883,222 180,500,000 205,000,000 277,500,000 3,079,334 277,500,000 20,506,852 216,161,432 3,079,334 33,632,966 375,257,694 Net Profit for The Year 262,522,286 Total Shareholders' Equity 960,269,904 328,770,981 1,223,240,975 Non-Current Portion of Medium-Term Loan 348,178,901 515,384,422 Non-Current Notes Payable 4,778,896 Other Non-Current Liabilities 30,359,715 26,949,470 Non-Current Portion of Obligation Under Finance Lease 34,115,016 Total Long-term Liabilities 383,317,512 576,448,908 Credit Facilities 65,086,924 Contingency Provision 70,400,142 276,910,119 80,161,571 Customers Advance Payments 5,276,517 5,874,096 Current Portion of Land Creditors Current Portion of Obligation Under Finance Lease Trade and Notes Payable Current Portion of Medium-Term Loan Income Tax 4,753,050,593 38,849,572 15,490,486 5,656,995,735 197,100,483 Creditors & Other Credit Balances 79,873,408 50,741,080 86,919,769 Total Current Liabilities 5,012,537,156 6,370,193,339 Total Liabilities & Shareholders' Equity 6,356,124,572 8,169,883,222 Source: Company Management ibnsinapharma 33 33

View entire presentation